Results 271 to 280 of about 48,228 (282)

Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

Lancet, The, 2013
Marina Cuchel, Dirk J Blom, A David Marais   +2 more
exaly  

Complement, a target for therapy in inflammatory and degenerative diseases

Nature Reviews Drug Discovery, 2015
exaly  

Rapid selection of complement-inhibiting protein variants in group A Streptococcus epidemic waves

Nature Medicine, 1999
Slawomir Lukomski, Allison J Mcgeer, David de Lorenzo   +2 more
exaly  

SWITCH TO AROMATASE INHIBITOR BETTER THAN CONTINUING TAMOXIFEN

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Complement inhibitor C4b-binding protein—friend or foe in the innate immune system?

Molecular Immunology, 2004
Bruno O Villoutreix, Björn Dahlbäck, Anna Blom   +2 more
exaly  

COMPLEMENT AND C3-PROACTIVATOR LEVELS IN CHILDREN WITH PROTEIN-CALORIE MALNUTRITION AND EFFECT OF DIETARY TREATMENT

Lancet, The, 1973
exaly  

Terminal Complement Inhibitor Eculizumab in Atypical Hemolytic–Uremic Syndrome

New England Journal of Medicine, 2013
exaly  

A small-molecule inhibitor of C5 complement protein

Nature Chemical Biology, 2019
Mitsunori Kato, Christian Wiesmann, Philippe Bolduc   +2 more
exaly  

The Protein Kinase Complement of the Human Genome

Science, 2002
exaly  

Evaluating the efficacy and safety of pozelimab in patients with CD55 deficiency with hyperactivation of complement, angiopathic thrombosis, and protein-losing enteropathy disease: an open-label phase 2 and 3 study

Lancet, The
Ahmet Ozen, Jessica Jacqueline Jalbert, Hagit Baris-Feldman   +2 more
exaly